Hemodialysis Catheter Articles & Analysis
5 news found
This QDIP designation applies to the use of BTX 1901 to potentially ‘reduce the risk of Staph. aureus bloodstream infections in colonised patients dependent on central venous catheters for hemodialysis’, the lead indication for our novel intranasal gel. ...
“We report on a patient with a history of multiple central venous catheters which resulted in the development of venous occlusion and the need for the placement of their catheter in a femoral vein. Using the Surfacer System, we were able to cross the patient’s central venous occlusion and obtain central venous access which facilitated the placement of ...
” Thoracic central venous obstruction occurs in roughly 40% of patients where hemodialysis is performed via a central venous catheter.[1] While permanent arteriovenous fistulas are the preferred form of vascular access for hemodialysis patients, central venous catheters continue to serve as an important bridge to securing ...
The use of the Surfacer System to gain central venous access and enable the placement of transvenous cardiac leads combined with the demonstrated adoption of our technology for use in patients requiring central venous catheters for hemodialysis and other therapies represent extremely large market opportunities for the use of our device.” About the ...
The OptionELITE™ Retrievable Vena Cava Filter, CLEANER™ Rotational Thrombectomy System, and UltraStream™ Chronic Hemodialysis Catheter are now wholly owned by Argon Medical Devices, Inc. ...